Sevoflurane vs propofol in high risk cardiac surgery: Design of the randomized trial Sevo-Aifa

Signa Vitae

Volumn 6, Issue 1, 2011, Pages 36-40

  Landoni, Giovanni ^a   Guarracino, Fabio ^a   Baldassarri, Rubia ^a   Cariello, Claudia ^a   Gerli, Chiara ^b,c   Fano, Greta ^b,c   de Simone, Francesco ^b,c   Cassarà, Luigi ^b,c   Frati, Elena ^b,c   Pittarello, Demetrios ^a,d   Tritapepe, Luigi ^a,e   Zangrillo, Alberto ^b,c  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c UNIVERSITY HOSPITAL OF PISA   (Italy)

^d Department of Cardiac Anesthesia Padova ^*  (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Anesthetic gases; Cardiac anesthesia; Cardiac surgical procedures; Intensive care; Myocardium protection; Sevoflurane; Volatile agents

Indexed keywords

PROPOFOL; SEVOFLURANE;

ARTICLE; CONVALESCENCE; CORONARY ARTERY SURGERY; HEART INJURY; HEART PROTECTION; HEART SURGERY; HEART VALVE SURGERY; HIGH RISK PATIENT; HUMAN; INTENSIVE CARE UNIT; INTRAVENOUS ANESTHESIA; LENGTH OF STAY; METHODOLOGY; MULTICENTER STUDY (TOPIC); PATIENT TRANSPORT; PERIOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIAL (TOPIC); SURGICAL MORTALITY; TISSUE PERFUSION;

EID: 79957558775     PISSN: 13345605     EISSN: 1845206X     Source Type: Journal    
DOI: 10.22514/SV61.042011.6     Document Type: Article

References (26)

1. Eagle KA, Guyton RA, Davidoff R, Edwards FH, Ewy GA, Gardner TJ, et al. American College of Cardiology; American Heart Association. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation 2004;110:e340-437.
2. Slogoff S, Keats AS. Randomized trial of primary anesthetic agents on outcome of coronary artery bypass operations. Anesthesiology 1989;70:179-88.
3. Tuman KJ, McCarthy RJ, Spiess BD, DaValle M, Dabir R, Ivankovich AD. Does choice of anesthetic agent significantly affect outcome after coronary artery surgery? Anesthesiology 1989;70:189-98.
4. De Hert SG, Turani F, Mathur S, Stowe DF. Cardioprotection with volatile anesthetics: mechanisms and clinical implications. Anesth Analg 2005;100:1584-93.
5. Chiari P, Bouvet F, Piriou V. Anaesthetic-induced myocardial preconditioning: fundamental basis and clinical implications. Ann Fr Anesth Reanim 2005;24:383-96.
6. De Hert SG. Volatile anesthetics and cardiac function. Semin Cardiothorac Vasc Anesth 2006;10:33-42.
7. De Hert SG. The concept of anaesthetic-induced cardioprotection: clinical relevance. Best Pract Res Clin Anaesthesiol 2005;19:445-59.
8. Landoni G, Bignami E, Oliviero F, Zangrillo A. Halogenated anaesthetics and cardiac protection in cardiac and non-cardiac anaesthesia. Ann Card Anaesth 2009;12:4-9.
9. Landoni G, Fochi O, Torri G. Cardiac protection by volatile anaesthetics: a review. Curr Vasc Pharmacol 2008;6:108-11.
10. Landoni G, Biondi-Zoccai GG, Zangrillo A, Bignami E, D'Avolio S, Marchetti C, et al. Desflurane and sevoflurane in cardiac surgery: a meta-analysis of randomized clinical trials. J Cardiothorac Vasc Anesth 2007;21:502-11.
11. Tritapepe L, Landoni G, Guarracino F, Pompei F, Crivellari M, Maselli D, et al. Cardiac protection by volatile anaesthetics: a multicentre randomized controlled study in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass. Eur J Anaesthesiol 2007;24:323-31.
12. De Hert SG, Van der Linden PJ, Cromheecke S, Meeus R, ten Broecke PW, De Blier IG, et al. Choice of primary anesthetic regimen can influence intensive care unit length of stay after coronary surgery with cardiopulmonary bypass. Anesthesiology 2004;101:9-20.
13. De Hert SG, Van der Linden PJ, Cromheecke S, Meeus R, Nelis A, Van Reeth V, et al. Cardioprotective properties of sevoflurane in patients undergoing coronary surgery with cardiopulmonary bypass are related to the modalities of its administration. Anesthesiology 2004;101:299-310.
14. Guarracino F, Landoni G, Tritapepe L, Pompei F, Leoni A, Aletti G, et al. Myocardial damage prevented by volatile anesthetics: a multicenter randomized controlled study. J Cardiothorac Vasc Anesth 2006;20:477-83.
15. Conzen PF, Fischer S, Detter C, Peter K. Sevoflurane provides greater protection of the myocardium than propofol in patients undergoing off-pump coronary artery bypass surgery. Anesthesiology 2003;99:826-33.
16. Bein B, Renner J, Caliebe D, Scholz J, Paris A, Fraund S, et al. Sevoflurane but not propofol preserves myocardial function during minimally invasive direct coronary artery bypass surgery. Anesth Analg 2005;100:610-6.
17. Bignami E, Landoni G, Crescenzi G, Gonfalini M, Bruno G, Pappalardo F, et al. Role of cardiac biomarkers (troponin I and CK-MB) as predictors of quality of life and long-term outcome after cardiac surgery. Ann Card Anaesth 2009;12:22-6.
18. Landoni G, Calabrò MG, Marchetti C, Bignami E, Scandroglio AM, Dedola E, et al. Desflurane versus propofol in patients undergoing mitral valve surgery. J Cardiothorac Vasc Anesth 2007;21:672-7.
19. Cromheecke S, Pepermans V, Hendrickx E, Lorsomradee S, Ten Broecke PW, Stockman BA, et al. Cardioprotective properties of sevoflu- rane in patients undergoing aortic valve replacement with cardiopulmonary bypass. Anesth Analg 2006;103:289-96.
20. Kato R, Foex P. Myocardial protection by anesthetic agents against ischemia-reperfusion injury: An update for anesthesiologists. Can J Anaesth 2002;49:777-791.
21. Landoni G, Fochi O, Bignami E, De Simone F, Zangrillo A. Volatile anesthetics for periprocedural cardiac protection. A review. Minerva Cardioangiol 2008;56:429-34.
22. Landoni G, Fochi O, Tritapepe L, Guarracino F, Belloni I, Bignami E, et al. Cardiac protection by volatile anesthetics. A review. Minerva Anestesiol 2009;75:269-73.
23. Bignami E, Biondi-Zoccai G, Landoni G, Fochi O, Testa V, Sheiban I, et al. Volatile Anesthetics Reduce Mortality in Cardiac Surgery. J Cardiothorac Vasc Anesth 2009;23:594-9.
24. Landoni G, Augoustides JG, Guarracino F, Santini F, Ponschab M, Pasero D, et al. Mortality reduction in cardiac anesthesia and inten- sive care: results of the first International Consensus Conference. Hsr proceedings in intensive care and cardiovascular anesthesia. 2011;3:9-19.
25. Landoni G, Fochi O, Bignami E, Calabrò MG, D'Arpa MC, Moizo E, et al. Cardiac protection by volatile anesthetics in non-cardiac surgery? A meta-analysis of randomized controlled studies on clinically relevant endpoints. Hsr proceedings in intensive care and cardiovascular anesthesia. 2011;2:34-43.
26. Landoni G, Zangrillo A, Fochi O, Maj G, Scandroglio AM, Morelli A, et al. Cardiac protection with volatile anesthetics in stenting procedures. J Cardiothorac Vasc Anesth 2008;22:543-7.